The Bombay Burmah Trading Corporation Limited
Valuation (94/100) does the heavy lifting; momentum (23/100) is the drag.
Buy zoneThe Bombay Burmah Trading Corporation Limited earns a Buy from StocksWizard, with a blended score of 69/100. At ₹1,498.1 it trades below our blended DCF and relative-multiples fair value of ₹2,996.2, about 100% upside to that estimate — we read it as undervalued by 100%. On 8.2x trailing earnings it sits cheaper than the Consumer Defensive median of about 26.1x. The price is about 28% below its 52-week high of ₹2,083.07 and 13% above the low of ₹1,322. Financial health scores 50/100, in the grey band on the Altman Z-score, with a Piotroski F-score of 8/9. It clears 7 of 13 investability checks, with durability 70, valuation 88 and momentum 23 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹2,396.96. Low-confidence estimate — limited data.
1-year price
EOD · 2026-07-2952-week range
-28.08% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Buy69Piotroski F-score 8/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 28.7%
- Pass: Low debt (D/E < 0.5): 0.17x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: 8%
- Pass: Earnings growing: 44%
- Fail: Net margin ≥ 10%: 6.3%
- Fail: Current ratio > 1.5: 1.19
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 2.98
- Pass: Piotroski ≥ 7: 8/9
Annual financials
Shareholding
- Promoter75.2%
- Institutions6.9%
- Public & other17.8%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Strong return on equity (28.7%).
- Lightly leveraged balance sheet.
- High Piotroski quality score (8/9).
Opportunities
- Earnings growing (44% YoY).
- Trading in our value buy zone versus sector peers.
- Trades ~100% below our estimated fair value.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
About The Bombay Burmah Trading Corporation Limited
Bombay Burmah Trading Corporation Limited operates tea and coffee plantations, manufactures auto electric components, provides healthcare services, and develops real estate across India and internationally. The company produces and trades tea, coffee, timber, cardamom, and pepper through its plantation segment, manufactures dental products, and operates horticulture, food, bakery, and dairy businesses across six operational segments.
The Bombay Burmah Trading Corporation Limited — frequently asked questions
Is The Bombay Burmah Trading Corporation Limited a buy, hold or sell?
StocksWizard currently rates The Bombay Burmah Trading Corporation Limited (BBTC) a Buy, based on a blended score of 69/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is The Bombay Burmah Trading Corporation Limited's fair value?
Our blended DCF and relative-valuation model estimates The Bombay Burmah Trading Corporation Limited's fair value at about ₹2,996.2, versus a current price of ₹1,498.1 — roughly 100% upside. On that basis the stock looks undervalued by 100%.
Is The Bombay Burmah Trading Corporation Limited financially healthy?
The Bombay Burmah Trading Corporation Limited scores 50/100 on our financial-health model, placing it in the grey band on the Altman Z-score, with a Piotroski F-score of 8/9.
How has The Bombay Burmah Trading Corporation Limited's share price performed?
The Bombay Burmah Trading Corporation Limited is roughly flat over three months, and last traded at ₹1,498.1. Past performance doesn't predict future returns.
More in Consumer Defensive
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.